RVRajeswar Rao Vedula

Rajeswar Rao Vedula

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rajeswar Rao Vedula has a total of 85 co-authors. Here are the top co-authors by number of shared publications:

  • Krishnaiah Vaarla

    Department of Chemistry, National Institute of Technology, Warangal, Telangana State, India

    11 shared publications
  • Santhosh Penta

    Department of Chemistry National Institute of Technology Raipur Chhattisgarh 492010 India

    9 shared publications
  • Raju Chedupaka

    Department of Chemistry National Institute of Technology Warangal Telangana India

    8 shared publications
  • Kodam Sujatha

    Department of Chemistry, National Institute of Technology, Warangal, Telangana, India

    7 shared publications
  • Papisetti Venkatesham

    National Institute of Technology Warangal, Telangana India. 506004

    7 shared publications
  • Sreenu Pavurala

    Department of Chemistry, National Institute of Technology, Warangal, India

    7 shared publications

Latest Publications

  • An efficient one‐pot, three‐component synthesis of novel [1,2,4]triazolo [4′,3′:1,5][1,2,4]triazolo[3,4‐b][1,3,4]thiadiazine derivatives and their molecular docking studies

    by Parameshwara Chary Jilloju, Perugu Shyam, Seema Aravind, Rajeswar Rao Vedula

    A series of novel [1,2,4]triazolo[4′,3′:1,5][1,2,4]triazolo[3,4‐b][1,3,4]thiadiazines (4a‐p) were synthesized from the reaction of 4‐amino‐5‐hydrazinyl‐4H‐1,2,4‐triazole‐3‐thiol (1) with different bromoethanones (2a‐p) and substituted benzoic acids (3) via a one‐pot, three‐component reaction with good to excellent yields. The new fused tri‐cyclic system was achieved without using a catalyst and metal by cyclo‐condensation reaction through a one‐pot approach. The structures of newly synthesized molecules were confirmed by using IR, 1H‐NMR, 13C‐NMR, Mass spectral, and analytical data. Molecular docking studies were carried out for the newly synthesized compounds against human cancer receptors (2TKB) with good results.


  • Nano Based Thiazole as a Potent Anticancer Agent and its In-Silico Molecular Docking and ADMET Prediction Studies

    by Srikanth Mamidala, R. Kowshik Aravilli, Venkata Bharat Nishtala, Ramesh Gondru, Rajeswar Rao Vedula

  • Efficient Four‐Component Synthesis of 1,2,4‐Triazolo[1,5‐ a ]pyrimidines and Their In Vitro Antiproliferative Studies

    by Papisetti Venkatesham, Mansi Kalonia, Akanksha Ashok Sangolkar, Anwita Mudiraj, Phanithi Prakash Babu, Rajeswar Rao Vedula

    Triazolopyrimidines are emerging as potential anticancer agents. Herein, we report a novel one‐pot four component synthesis of 2‐((2‐oxo‐2‐phenylethyl/benzyl)thio)‐10‐phenyl‐4,10‐dihydro‐9 H ‐indeno[1,2‐ d ][1,2,4]‐Triazolo[1,5‐ a ]pyrimidin‐9‐ones by the reaction of 1,3‐indanedione, aromatic aldehyde, 5‐amino‐4 H ‐1,2,4‐Triazol‐3‐thiol and phenacyl bromide in acetic acid with piperidine as catalyst at 90 °C for 13 hours. All the final compounds were identified on the basis of their FT‐IR, 1 H NMR, 13 C NMR and HRMS. The synthesized compounds were evaluated for their cell growth inhibition potential using MTT and wound healing assay, 13 compounds induced concentration dependent inhibition with IC 50 below 10 μM against breast cancer cell lines (MCF‐7). Further, the molecular docking simulation were carried out for all the derivatives, amongst these thio phenacyl, 2,4‐dichlorophenyl 9 H ‐indeno [1,2,4]‐Triazolo[1,5‐ a ]pyrimidin‐9‐one ( 5 g ) shows good binding interaction with amino acid residues. This is further confirmed by wound healing assay which shows that 5 g inhibits cell migration at increasing concentrations.


  • Novel one‐pot synthesis of imidazo[2,1‐b] [1, 2, 4]‐Triazoles, 1,2,4‐Triazolo iminoindoline‐2‐ones, and their in‐vitro antibacterial activity,B‐DNAstudy

    by Papisetti Venkatesham, Sreenivasa Rao Parcha, Soumya Lipsa Rath, Raju Chedupaka, Rajeswar Rao Vedula

    New series of 2‐(benzylthio)‐6‐phenyl‐4H‐imidazo[1,2‐b][1,2,4]‐Triazoles and benzylthio‐4H‐1,2,4‐Triazolo iminoimdoline‐2‐ones have been synthesized via a one‐pot process. Further, all the synthesized compounds were screened for their antibacterial activity against Gram‐positive, Gram‐negative bacteria. Among these tested compounds,5a–jhave shown promising antibacterial activity usingB. subtilisand studied for B‐DNA binding.


  • Design, synthesis, molecular docking, and dynamic studies of novel thiazole derivatives incorporating benzimidazole moiety and assessment as antibacterial agents

    by Raju Chedupaka, Amrutha V. Audipudi, Akanksha Ashok Sangolkar, Srikanth Mamidala, Papisetti Venkatesham, Santhosh Penta, Rajeswar Rao Vedula

    A general and sustainable approach for the synthesis of benzimidazole-thiazole compounds via an efficient, one-pot, domino, pseudo-four-component reaction using 5-amino-2-mercaptobenzimidazole, aralkyl halides, ammonium thiocyanate, and substituted α-bromo-acetophenones in glacial acetic acid at ambient temperature to give final compounds (4a–p) in good yields in shorter time. The spectral data of synthesized compounds were evaluated by analytical and spectral techniques (IR, 1H-NMR, 13C-NMR, and ESI-HRMS). Further, some of the synthesized compounds were screened for their in-vitro antibacterial activity studies using the agar well diffusion method against Gram-positive Streptococcus pneumoniae (2451) bacteria and Gram-negative Proteous mirabilis (2081) bacteria. Based on the MIC results, it was observed that the most active compounds 4b, 4e, 4f, and 4k show promising antibacterial activity with the zone of inhibition values of 2.85 cm 2.75 cm, 3.6 cm, and 3.3 cm against both Gram-negative and positive bacteria cell lines, respectively. Further, we have also insight into the molecular simulation studies, based on the binding results, compound 4i showed stable binding interactions with streptomycin drug with the active site of the gyrase protein (PDB ID: 1KIJ). The structure–activity relationship (SAR) studies of all the title scaffolds were also established. The antibacterial activity, molecular docking studies, and molecular dynamic simulations of the title compounds suggested that these are promising antibacterial active skeletons. Graphical abstract

  • Open Access

    Domino, one-pot, three-component synthesis, anti-bacterial and molecular modelling studies of novel benzimidazole based isoindoline-1,3-dione and benzo[4,5]imidazo[2,1-b]thiazol hybrids

    by Raju Chedupaka, Shyam Perugu, Srikanth Mamidala, Papisetti Venkatesham, Santhosh Penta, Rajeswar Rao Vedula

    A series of metal-free, thioalkylated benzimidazole-based isoindoline-1,3-dione (4a-w) and N-fused 4,5-benzo[4,5]imidaz[2,1-b]thiazole (5a-h) derivatives were synthesized via a novel, one-pot three-component approach. All the synthesized scaffolds were well characterized by analytical and spectroscopic techniques. The usefulness of this reaction is that it involves easy workup, shorter reaction time, broad substrate scope, and column-free purification of the products. Further, the synthesized scaffolds (4a-w) were evaluated for their in-vitro anti-microbial activity using two Gram-positive and two Gram-negative bacterial cell lines Escherichia coli, Salmonella typhi, Staphylococcus aureus and Micrococcus luteus by agar well diffusion method. Among tested compounds, compounds 4a, 4g, 4j, 4q, 4s, and 4t showed significant invitro antibacterial activity against Gram-positive and Gram-negative bacterial cell lines. Further, we have also insight of molecular docking studies, based on the docking results compounds 4s, 4j, 4a, 4q, 4t, and 4g have shown stable binding interaction with streptomycin drug with active site of the B-DNA (PDB ID: 1BNA). The antibacterial activity, and molecular docking studies of the title compounds were suggested that these are promising anti-bacterial active skeletons.

  • Open Access

    One-pot, three-component synthesis, anti-bacterial and molecular modelling studies of novel benzimidazole based isoindoline-1,3-dione and benzo[4,5]imidazo[2,1-b]thiazol hybrids

    by Raju Chedupaka, Shyam Perugu, Srikanth Mamidala, Venkatesham Papisetti, Santhosh Penta, Rajeswar Rao Vedula

    A series of metal-free, thioalkylated benzimidazole-based isoindoline-1,3-dione (4a-w) and N-fused 4,5-benzo[4,5]imidaz[2,1-b]thiazole (5a-h) derivatives were synthesized via a novel, one-pot three-component approach. All the synthesized scaffolds were well characterized by analytical and spectroscopic techniques. The usefulness of this reaction is that it involves easy workup, shorter reaction time, broad substrate scope, and column-free purification of the products. Further, the synthesized scaffolds (4a-w) were evaluated for their in-vitroanti-microbial activity using two Gram-positive and two Gram-negative bacterial cell lines Escherichia coli, Salmonella typhi, Staphylococcus aureus and Micrococcus luteus by agar well diffusion method. Among tested compounds, compounds 4a, 4g, 4j, 4q, 4s, and 4t showed significant invitro antibacterial activity against Gram-positive and Gram-negative bacterial cell lines. Further, we have also insight of molecular docking studies, based on the docking results compounds 4s, 4j, 4a, 4q, 4t, and 4g have shown stable binding interaction with streptomycin drug with active site of the B-DNA (PDB ID: 1BNA). The antibacterial activity, and molecular docking studies of the title compounds were suggested that these are promising anti-bacterial active skeletons.

  • Recent Developments in Multi-component Synthesis of Lawsone Derivatives

    by Rajeswar Rao Vedula, Santhosh Penta, Rajender S. Varma, Komal Chandrakar, Jeevan Lal Patel, R. K. Virendra, Shayama Prasad Mahapatra

    Background: 2-Hydroxy-1,4-Naphthoquinone (HNQ; Lawsone) is one of the most useful and the simplest naturally occurring naphthoquinones and has stimulated a resurgence of interest in the past decades due to a wide range of pharmacological activities. Introduction and Method: This activity has led to the unusually large emphasis being placed on the design of more efficient multi-component reactions (MCRs) in the synthesis of bioactive lawsone derivatives. Results and Conclusion: This review highlights the recent developments in multi-component synthesis of biologically relevant naphthoquinone linked and fused heterocyclic derivatives carried out from 2015 till now.


  • Open Access

    Facile, One-pot, pseudo four component synthesis of novel benzimidazolyl- thiazoles via multi-component approach and their biological evaluation

    by Raju Chedupaka, Amrutha V Audipudi, Akansha Ashok Sangolkar, Srikanth Mamidala, Papisetti Venkatesham, Santhosh Penta, Rajeswar Rao Vedula

    A general and sustainable multicomponent approach for the synthesis of benzimidazolyl-thiazole compounds via an efficient, one-pot, pseudo four-component reaction using 5-amino-2-mercaptobenzimidazole, aralkyl halides, ammonium thiocyanate, and substituted α-bromo-acetophenones in glacial acetic acid at ambient temperature to give final compounds (4a-p) in good yields in shorter time. The spectral data of synthesized compounds were evaluated by analytical and spectral techniques (IR, 1H-NMR, 13C-NMR, and ESI-HRMS). Further, some of the synthesized compounds were screened for their in-vitro antibacterial activity studies using the agar well diffusion method against Gram-positive Streptococcus Pneumoniae (2451) bacteria and Gram-negative Porteous Mirabilis (2081) bacteria. Based on the MIC results, it was observed that the most active compounds 4b, 4e, 4f, and 4k are shown promising anti-bacterial activity with the zone of inhibition values of 2.85 cm 2.75 cm, 3.6 cm, and 3.3 cm against both Gram-negative and Gram-positive bacteria cell lines respectively. Further, we have also insight into the molecular simulation studies, based on the binding results, compound 4i showed stable binding interactions with streptomycin drug with active site of the gyrase protein (PDB ID: 1KIJ). The structure-activity relationship (SAR) studies of all the title scaffolds were also established. The antibacterial activity, molecular docking studies, molecular dynamic simulations of the title compounds were suggested that these are promising anti-bacterial active skeletons.


  • Synthesis, characterization and Density Functional Theory of novel one-pot thioalkylated benzimidazole-linked 4-substituted mercaptoimidazole molecular hybrids via multi-component approach

    by Raju Chedupaka, Ravinder Pawar, Papisetti Venkatesham, Rajeswar Rao Vedula

    A series of novel, one-pot, four components synthetic procedure has been developed for the synthesis of thioalkylated benzimidazole-linked 4-substituted mercaptoimidazole molecular hybrids and their benzyl derivatives (4a–j) and (5a–f) were synthesized by the reaction of 5-amino-2-mercaptobenzimidazole, with different substituted phenacyl bromides/aryl alkyl halides in the presence of glacial acetic acid and fused sodium acetate under reflux condition to give corresponding intermediates. These compounds on further reaction with ammonium thiocyanate via multi-component reaction to give the title compounds (4a–j) and (5a–f). All the newly synthesized compounds were well characterized by their spectral and analytical studies. This procedure includes several advantages such as transition metal-free, catalyst-free, mild reaction temperature, shorter reaction time, and gives good to excellent yields without any column purification techniques. Further, mechanistic insight into the formation of the final products has also been provided based on their density functional theory (DFT) studies. Graphical Abstract